Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
16.04
-0.89 (-5.23%)
Streaming Delayed Price
Updated: 10:36 AM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Stocks I'd Avoid at All Costs
July 13, 2021
On the surface, these companies seem like underpriced investments, but look a little closer and there's a good reason to stay away.
Via
The Motley Fool
Stay Away From Low-Growth Organon
July 08, 2021
Organon's low growth, lack of strong catalysts and likely average future dividend combine to make OGN stock unattractive.
Via
InvestorPlace
Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
June 29, 2021
From
Organon & Co.
Via
Business Wire
Summer Friday
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Via
Talk Markets
Don’t Miss the Opportunity Presented by Organon Stock
June 23, 2021
If a company's spun off from a pharmaceutical giant, you'd think the buzz about it would be deafening. Yet OGN stock remains an underappreciated gem.
Via
InvestorPlace
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
Organon Announces Filing of Form 10-Q for the Quarter Ended March 31, 2021
June 21, 2021
From
Organon & Co.
Via
Business Wire
Motivation Really Matters When It Comes to Organon
June 17, 2021
Though spun-off entities can perform very well, with OGN stock, you should assess which company is getting the better deal.
Via
InvestorPlace
Organon Completes Acquisition of Alydia Health – A Medical Device Company Focused on Postpartum Hemorrhage
June 16, 2021
From
Organon & Co.
Via
Business Wire
Continued Uncertainty
June 15, 2021
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
Dreary Day
June 14, 2021
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
Unheeding Markets
June 10, 2021
Today oil prices rose over $70.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
June 10, 2021
Upgrades According to Argus Research, the prior rating for Zoom Video Communications Inc (NASDAQ:ZM) was changed from Hold to Buy. Zoom Video Communications earned $1.32...
Via
Benzinga
Juvenile Investing Mob
June 08, 2021
Tech stocks did well in Europe but not in the US. The data are unconvincing.
Via
Talk Markets
FDA surprise
June 07, 2021
The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year.
Via
Talk Markets
Exposures
Product Safety
Merck Completes Women's Health Organon Spinoff
June 03, 2021
In a move to free up a cash windfall and streamline the business, Merck & Co Inc (NYSE: MRK) had long planned to slice away its women’s health business into a...
Via
Benzinga
ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company
June 03, 2021
From
Organon
Via
Business Wire
Inside Merck's Organon Spinoff And Why It Could Be Worth Billions
June 03, 2021
Don't think of Merck spinoff Organon as a research engine. The new pharmaceutical stock — which begins active trading on Thursday — is a commercial entity.
Via
Investor's Business Daily
Organon Launches as New Global Women’s Health Company
June 03, 2021
From
Organon & Co.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.